Business Wire CEO: Reported Fake Release To FBI
21 Junho 2010 - 11:33AM
Dow Jones News
News release service Business Wire has reported a fake press
release involving Javelin Pharmaceuticals Inc. (JAV) that ran on
its service Friday night to the Federal Bureau of Investigation,
Business Wire Chief Executive Cathy Tamraz said.
The FBI couldn't immediately be reached. Tamraz said her firm
has reported the case to the New York bureau of the FBI, and the
case is being treated as a "criminal investigation."
Javelin Pharmaceuticals Monday morning announced that on June 18
Business Wire inadvertently issued a hoax press release titled "US
Supreme Court split -- rules in favor of Big Pharma" that falsely
identified Javelin Pharmaceuticals as the issuer of the
information. The information in the hoax release was false,
Javelin's statement said. Business Wire received the hoax release
from an unknown third party, purporting to be an authorized
representative of the company, Javelin's Monday statement said.
-By Anjali Cordeiro, Dow Jones Newswires; 212-416-2200;
anjali.cordeiro@dowjones.com
Javelin Pharmaceuticals (AMEX:JAV)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Javelin Pharmaceuticals (AMEX:JAV)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Javelin Pharmaceuticals da American Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Javelin Pharmaceuticals Inc.